MDClone
Founded Year
2016Stage
Series C | AliveTotal Raised
$104MLast Raised
$63M | 2 yrs agoAbout MDClone
MDClone is a healthcare data platform. The platform generates datasets combining real and fictitious patients, allowing researchers to conduct tests without exposing sensitive medical data and compromising personal details. It was founded in 2016 and is based in Beer-Sheva, Israel.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
ESPs containing MDClone
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The synthetic patient data market offers a valuable solution for healthcare organizations and researchers. By leveraging synthetic patient data, which is artificial but realistic patient information, organizations can overcome challenges related to data privacy, security, and limited access to real patient data. Synthetic patient data provides a safe and compliant environment for testing, research…
MDClone named as Leader among 10 other companies, including Aetion, Aitia, and Gretel.
Expert Collections containing MDClone
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MDClone is included in 4 Expert Collections, including Digital Health 150.
Digital Health 150
150 items
The most promising digital health startups transforming the healthcare industry
Conference Exhibitors
5,302 items
Cybersecurity
6,928 items
These companies protect organizations from digital threats.
Digital Health
10,565 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
MDClone Patents
MDClone has filed 8 patents.
The 3 most popular patent topics include:
- Graphical user interface elements
- Health informatics
- Servers (computing)
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/18/2019 | 4/13/2021 | Health informatics, Graphical user interface elements, Electronic health records, Memory processes, Servers (computing) | Grant |
Application Date | 3/18/2019 |
|---|---|
Grant Date | 4/13/2021 |
Title | |
Related Topics | Health informatics, Graphical user interface elements, Electronic health records, Memory processes, Servers (computing) |
Status | Grant |
Latest MDClone News
Aug 2, 2023
News provided by Share this article Share this article Secure platform with embedded synthetic data technology enables life sciences to dynamically explore robust data needed to answer complex healthcare questions BEER-SHEVA, Israel, Aug. 2, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that in the last year it has established partnerships with multiple life sciences organizations to accelerate research and discovery processes through dynamic data exploration. Via its Connect Platform, MDClone connects life science organizations to rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies. Featuring embedded synthetic data technology to preserve patient privacy, the Connect platform enables life science organizations to identify sites, analyze robust structured and unstructured real-world data, and explore populations of interest with incredible detail and flexibility. The research and discovery process for many life science organizations is plagued by fragmented data assets, limited access to clinical information, and long timelines, which hinder the ability to innovate. MDClone helps life sciences overcome these barriers by providing quick access to robust real-world data sets needed to answer complex healthcare questions. MDClone's life sciences partners access real-world evidence through the Global Network, a member-driven collaborative that empowers the largest and most innovative organizations in the world to join forces on life-saving projects. The Global Network features synthetic data sets built from >500 million encounters at leading global health institutions in the U.S., Canada, and Israel, such as Intermountain Healthcare, The Ottawa Hospital, and Sheba Medical Center. "By instantly delivering self-service access to rich, high-quality, synthetic data, MDClone's Connect platform provides the best of both worlds for life sciences researchers – granular-level detail for real-world evidence with enhanced privacy preservation to protect patients," said Josh Rubel, Chief Commercial Officer, MDClone. "We look forward to expanding our life sciences partnerships to help drug and device developers confidently move forward with research and projects of interest that hold the potential to shape the future of healthcare with rapid, data-driven learning, collaboration, and innovation at the forefront." Currently, MDClone's life sciences clients are exploring multiple use cases for the Connect Platform, including investigating the results of oral versus intravenous treatment for post-operative anemia, as well as determining the best treatment options for congestive heart failure patients. To learn more about how MDClone is reinventing life sciences innovation, click here . About MDClone MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems around the world. The powerful underlying workflow and synthetic infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel. Visit mdclone.com for more information. Media Contact:
MDClone Frequently Asked Questions (FAQ)
When was MDClone founded?
MDClone was founded in 2016.
Where is MDClone's headquarters?
MDClone's headquarters is located at 77 HaEnergia Street, Beer-Sheva.
What is MDClone's latest funding round?
MDClone's latest funding round is Series C.
How much did MDClone raise?
MDClone raised a total of $104M.
Who are the investors of MDClone?
Investors of MDClone include OrbiMed Advisors, Lightspeed Venture Partners, aMoon Fund, Warburg Pincus, Declaration Partners and 3 more.
Who are MDClone's competitors?
Competitors of MDClone include Briya, Rhino Health, Segmed, Statice, Diveplane and 10 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare MDClone to Competitors
Gesund.ai provides a platform focused on streamlining clinical validation of medical AI solutions and provides solutions for machine-learning algorithm development and validation. It offers hospitals, pharmaceutical firms, or researchers the medical learning infrastructure needed to develop artificial intelligence algorithms that fully abide by data standards while allowing users to work together on challenging problems without centralizing or sharing data. The company was founded in 2021 and is based in Cambridge, Massachusetts.
Unlearn builds machine-learning platforms to create biological digital twins for the healthcare and pharmaceutical industries. It develops generative machine learning methods to predict individual health outcomes and accelerate clinical innovation. It connects with biopharma companies and regulators to ensure its methods meet scientific and regulatory standards. The company was founded in 2017 and is based in San Fransisco, California.
Owkin specializes in developing artificial intelligence (AI) technologies for clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharmaceutical industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.
Synthesized provides a synthetic data generation platform. It helps engineering and data science teams to create and share data through machine learning and automation. It offers fraud modeling, test data management, compliant data sharing and collaboration, and synthetic data application. It creates data for machine learning, application development, and testing with easy-to-use configuration files. The company was founded in 2018 and is based in London, United Kingdom.
Tonic.ai provides a synthetic data platform. It creates mock data that preserves characteristics of secure datasets for developers, data scientists, and salespeople to work without breaching privacy. It was founded in 2018 and is based in San Francisco, California.
MOSTLY AI offers a synthetic data engine. It analyzes and provides insights related to consumer behavior, and builds predictive models by using deep learning, machine learning, and artificial intelligence technologies. The company provides its service to the banking, insurance, and telecommunications industries. It was founded in 2017 and is based in Vienna, Austria.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
